Literature DB >> 19047762

Development of a clinical prediction model to calculate patient life expectancy: the measure of actuarial life expectancy (MALE).

M G Clarke1, K P Kennedy, R P MacDonagh.   

Abstract

OBJECTIVES: To develop a clinical prediction model enabling the calculation of an individual patient's life expectancy (LE) and survival probability based on age, sex, and comorbidity for use in the joint decision-making process regarding medical treatment.
METHODS: A computer software program was developed with a team of 3 clinicians, 2 professional actuaries, and 2 professional computer programmers. This incorporated statistical spreadsheet and database access design methods. Data sources included life insurance industry actuarial rating factor tables (public and private domain), Government Actuary Department UK life tables, professional actuarial sources, and evidence-based medical literature. The main outcome measures were numerical and graphical display of comorbidity-adjusted LE; 5-, 10-, and 15-year survival probability; in addition to generic UK population LE.
RESULTS: Nineteen medical conditions, which impacted significantly on LE in actuarial terms and were commonly encountered in clinical practice, were incorporated in the final model. Numerical and graphical representations of statistical predictions of LE and survival probability were successfully generated for patients with either no comorbidity or a combination of the 19 medical conditions included. Validation and testing, including actuarial peer review, confirmed consistency with the data sources utilized.
CONCLUSIONS: The evidence-based actuarial data utilized in this computer program design represent a valuable resource for use in the clinical decision-making process, where an accurate objective assessment of patient LE can so often make the difference between patients being offered or denied medical and surgical treatment. Ongoing development to incorporate additional comorbidities and enable Web-based access will enhance its use further.

Entities:  

Mesh:

Year:  2008        PMID: 19047762     DOI: 10.1177/0272989X08327114

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  6 in total

Review 1.  A systematic literature review of life expectancy prediction tools for patients with localized prostate cancer.

Authors:  Matthew Kent; Andrew J Vickers
Journal:  J Urol       Date:  2014-11-15       Impact factor: 7.450

2.  A risk assessment model for chronic ankle instability: indications for early surgical treatment? An observational prospective cohort - study protocol.

Authors:  Gwendolyn Vuurberg; Lauren M Wink; Leendert Blankevoort; Daniel Haverkamp; Robert Hemke; Sjoerd Jens; Inger N Sierevelt; Mario Maas; Gino M M J Kerkhoffs
Journal:  BMC Musculoskelet Disord       Date:  2018-07-18       Impact factor: 2.362

3.  Comparison of Physician-Documented Versus Patient-Reported Collection of Comorbidities Among Patients With Prostate Cancer Upon First Visit to the Urology Clinic.

Authors:  Katherine Fleshner; Amy Tin; Nicole Benfante; Sigrid Carlsson; Andrew J Vickers
Journal:  JCO Clin Cancer Inform       Date:  2018-12

Review 4.  The implications of ageing and life expectancy in prostate cancer treatment.

Authors:  Sarathi Kalra; Spyridon Basourakos; Angela Abouassi; Mary Achim; Robert J Volk; Karen E Hoffman; John W Davis; Jeri Kim
Journal:  Nat Rev Urol       Date:  2016-03-22       Impact factor: 14.432

Review 5.  Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Frank C Detterbeck; Peter J Mazzone; David P Naidich; Peter B Bach
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

6.  Successful external validation of a model to predict other cause mortality in localized prostate cancer.

Authors:  Matthew Kent; David F Penson; Peter C Albertsen; Michael Goodman; Ann S Hamilton; Janet L Stanford; Antoinette M Stroup; Behfar Ehdaie; Peter T Scardino; Andrew J Vickers
Journal:  BMC Med       Date:  2016-02-09       Impact factor: 8.775

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.